How does PHLI's PB Ratio compare to its peers?

Insufficient data to calculate PHLI's Price-To-Book Ratio vs. peers for valuation analysis.

How does PHLI's PB Ratio compare vs other companies in the US Personal Products Industry?

Insufficient data to calculate PHLI's Price-To-Book Ratio vs. industry for valuation analysis.

What is PHLI's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate PHLI's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of PHLI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate PHLI's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

PacificHealth Laboratories (OTCPK:PHLI) - Stock Price, News & Analysis

PHLI Stock Overview

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. More details

PHLI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap ($20)

My Notes

Capture your thoughts, links and company narrative

PacificHealth Laboratories, Inc. Competitors

LifeQuest World

OTCPK:LQWC

US$1.1m

Nevis Brands

OTCPK:NEVI.F

US$1.9m

Shineco

NasdaqCM:SISI

US$2.4m

Cyanotech

OTCPK:CYAN

US$3.1m

Price History & Performance

Summary of share price highs, lows and changes for PacificHealth Laboratories
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-99.00%
3 Year Change	-100.00%
5 Year Change	-99.98%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PHLI	US Personal Products	US Market
7D	0%	-8.4%	1.2%
1Y	-99.0%	-31.4%	21.0%

Return vs Industry: PHLI underperformed the US Personal Products industry which returned -25.4% over the past year.

Return vs Market: PHLI underperformed the US Market which returned 23.9% over the past year.

Price Volatility

Is PHLI's price volatile compared to industry and market?
PHLI volatility
PHLI Average Weekly Movement	n/a
Personal Products Industry Average Movement	8.2%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: PHLI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PHLI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	n/a	n/a	www.pacifichealthlabs.com

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel.

PacificHealth Laboratories, Inc. Fundamentals Summary

How do PacificHealth Laboratories's earnings and revenue compare to its market cap?
PHLI fundamental statistics
Market cap	US$20.00
Earnings (TTM)	-US$943.60k
Revenue (TTM)	US$6.67m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PHLI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHLI income statement (TTM)
Revenue	US$6.67m
Cost of Revenue	US$4.10m
Gross Profit	US$2.57m
Other Expenses	US$3.51m
Earnings	-US$943.60k

Last Reported Earnings

Sep 30, 2012

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PHLI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/06 08:26
End of Day Share Price	2024/02/07 00:00
Earnings	2012/09/30
Annual Earnings	2011/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PacificHealth Laboratories, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.